Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 54
Filter
1.
Virulence ; 11(1): 995-1005, 2020 12.
Article in English | MEDLINE | ID: mdl-32799627

ABSTRACT

BURKHOLDERIA CEPACIA: is an opportunistic pathogen that infects patients with debilitating underlying diseases. This study investigated the production of outer membrane vesicles (OMVs) by B. cepacia cultured with sub-minimum inhibitory concentrations (MICs) of antibiotics and examined their pathogenic roles both in vitro and in vivo. B. cepacia ATCC 25416 produced more OMVs under antibiotic stress conditions than controls. OMVs isolated from B. cepacia cultured in Luria-Bertani (LB) broth (OMVs/LB) induced cytotoxicity and the expression of pro-inflammatory cytokine genes in A549 cells in a dose-dependent manner. Host cell cytotoxicity and pro-inflammatory responses were significantly higher in A549 cells treated with B. cepacia OMVs cultured with 1/4 MIC of ceftazidime (OMVs/CAZ) than in the cells treated with OMVs/LB, OMVs cultured with 1/4 MIC of trimethoprim/sulfamethoxazole (OMVs/SXT), or OMVs cultured with 1/4 MIC of meropenem. Intratracheal injection of B. cepacia OMVs also induced histopathology in vivo in mouse lungs. Expressions of IL-1ß and TNF-α genes were significantly up-regulatedin the lungs of mice treated with OMVs/CAZ compared to mice administered other OMVs; the expression of the GRO-α gene, however, was significantly up-regulated in OMVs/SXT. In conclusion, OMVs produced by B. cepacia under different antibiotic stress conditions induce different host responses that may contribute to the pathogenesis of B. cepacia.


Subject(s)
Anti-Bacterial Agents/pharmacology , Burkholderia cepacia/drug effects , Burkholderia cepacia/pathogenicity , Ceftazidime/pharmacology , Inflammation , Secretory Vesicles/drug effects , A549 Cells , Animals , Bacterial Outer Membrane/drug effects , Bacterial Outer Membrane/immunology , Burkholderia cepacia/immunology , Female , Humans , Mice , Mice, Inbred BALB C , Microbial Sensitivity Tests , Secretory Vesicles/immunology
2.
Hum Vaccin Immunother ; 12(3): 751-6, 2016 03 03.
Article in English | MEDLINE | ID: mdl-26618824

ABSTRACT

A great number of cystic fibrosis (CF) pathogens such as Pseudomonas aeruginosa, the Burkholderia cepacia and the Mycobacterium abscessus complex raised difficult therapeutic problems due to their intrinsic multi-resistance to numerous antibiotics. Vaccine strategies represent one of the key weapons against these multi-resistant bacteria in a number of clinical settings like CF. Different strategies are considered in order to develop such vaccines, linked either to priming the host response, or by exploiting genomic data derived from the bacterium. Interestingly, virulence factors synthesized by various pathogens might serve as targets for vaccine development and have been, for example, evaluated in the context of CF.


Subject(s)
Bacterial Vaccines/administration & dosage , Bacterial Vaccines/immunology , Cystic Fibrosis/complications , Drug Discovery/methods , Pneumonia, Bacterial/prevention & control , Burkholderia cepacia/immunology , Drug Discovery/trends , Humans , Mycobacterium/immunology , Pseudomonas aeruginosa/immunology
3.
Article in English | MEDLINE | ID: mdl-23386999

ABSTRACT

The genus Burkholderia consists of diverse species which includes both "friends" and "foes." Some of the "friendly" Burkholderia spp. are extensively used in the biotechnological and agricultural industry for bioremediation and biocontrol. However, several members of the genus including B. pseudomallei, B. mallei, and B. cepacia, are known to cause fatal disease in both humans and animals. B. pseudomallei and B. mallei are the causative agents of melioidosis and glanders, respectively, while B. cepacia infection is lethal to cystic fibrosis (CF) patients. Due to the high rate of infectivity and intrinsic resistance to many commonly used antibiotics, together with high mortality rate, B. mallei and B. pseudomallei are considered to be potential biological warfare agents. Treatments of the infections caused by these bacteria are often unsuccessful with frequent relapse of the infection. Thus, we are at a crucial stage of the need for Burkholderia vaccines. Although the search for a prophylactic therapy candidate continues, to date development of vaccines has not advanced beyond research to human clinical trials. In this article, we review the current research on development of safe vaccines with high efficacy against B. pseudomallei, B. mallei, and B. cepacia. It can be concluded that further research will enable elucidation of the potential benefits and risks of Burkholderia vaccines.


Subject(s)
Bacterial Vaccines/immunology , Burkholderia Infections/prevention & control , Burkholderia cepacia/immunology , Burkholderia mallei/immunology , Burkholderia pseudomallei/immunology , Cystic Fibrosis/complications , Animals , Burkholderia Infections/complications , Burkholderia Infections/microbiology , Cost-Benefit Analysis , Glanders/microbiology , Glanders/prevention & control , Humans , Melioidosis/microbiology , Melioidosis/prevention & control , Models, Animal , Vaccines, Attenuated , Vaccines, DNA , Vaccines, Inactivated
4.
Mikrobiologiia ; 81(3): 371-6, 2012.
Article in English | MEDLINE | ID: mdl-22880399

ABSTRACT

The flagellar protein (flagellin) was isolated and purified from strains of Pseudomonas aeruginosa, Burkholderia cepacia and Stenotrophomonas maltophilia. A significant difference was observed in the molecular weight of different flagellin preparations obtained from these bacterial isolates. Antiserum prepared against S. maltophilia flagellin did not react with flagellin of P. aeruginosa or/and B. cepacia on Immunoblot or in indirect ELISA. In addition the anti-flagellin did not agglutinate P. aeruginosa and B. cepacia. No inhibition of motility of P. aeruginosa and B. cepacia was observed in presence of antiserum; though the latter inhibited the motility of S. maltophilia. The results of the present study prove that no specific relationship existed among all the studied flagellar proteins obtained from closely related bacteria.


Subject(s)
Antibodies, Bacterial/immunology , Burkholderia cepacia , Flagellin , Pseudomonas aeruginosa , Stenotrophomonas maltophilia , Animals , Burkholderia cepacia/genetics , Burkholderia cepacia/immunology , Flagellin/genetics , Flagellin/immunology , Pseudomonas aeruginosa/genetics , Pseudomonas aeruginosa/immunology , Rabbits , Species Specificity , Stenotrophomonas maltophilia/genetics , Stenotrophomonas maltophilia/immunology
5.
J Microbiol Biotechnol ; 22(7): 907-16, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22580309

ABSTRACT

Burkholderia cepacia is an important pathogen that often causes pneumonia in immunocompromised individuals. Here, it was demonstrated that the TLR5 agonist flagellin could locally activate innate immunity. This was characterized by rapid expressions of IL-1beta, TNF-alpha, and iNOS mRNA and a delay in the expression of IL-10 mRNA. A significant elevation in the IL-1beta, TNF-alpha, and nitric oxide levels was also noted. In the respiratory tract, flagellin induced neutrophil infiltration into the airways, which was observed by histopathological examination and confirmed by the neutrophil count and level of myeloperoxidase activity. This was concomitant with a high activity of alveolar macrophages that engulfed and killed B. cepacia in vitro. The flagellin mucosal treatment improved the B. cepacia clearance in the mouse lung. Thus, the present findings illustrate the profound stimulatory effect of flagellin on the lung mucosal innate immunity, a response that needs to be exploited therapeutically to prevent the development of respiratory tract infection by B. cepacia.


Subject(s)
Bacterial Vaccines/immunology , Burkholderia Infections/prevention & control , Burkholderia cepacia/immunology , Flagellin/immunology , Respiratory Tract Infections/prevention & control , Animals , Bacterial Vaccines/administration & dosage , Burkholderia Infections/immunology , Flagellin/administration & dosage , Gene Expression , Histocytochemistry , Interleukin-10/biosynthesis , Interleukin-1beta/biosynthesis , Macrophages, Alveolar/immunology , Mice , Neutrophils/immunology , Nitric Oxide Synthase Type II/biosynthesis , Peroxidase/metabolism , Respiratory System/immunology , Respiratory System/pathology , Respiratory Tract Infections/immunology , Tumor Necrosis Factor-alpha/biosynthesis
6.
J Immunol ; 188(10): 5003-11, 2012 May 15.
Article in English | MEDLINE | ID: mdl-22491245

ABSTRACT

Chronic granulomatous disease (CGD) is an inherited disorder characterized by recurrent life-threatening bacterial and fungal infections. CGD results from defective production of reactive oxygen species by phagocytes caused by mutations in genes encoding the NADPH oxidase 2 (NOX2) complex subunits. Mice with a spontaneous mutation in Ncf1, which encodes the NCF1 (p47(phox)) subunit of NOX2, have defective phagocyte NOX2 activity. These mice occasionally develop local spontaneous infections by Staphylococcus xylosus or by the common CGD pathogen Staphylococcus aureus. Ncf1 mutant mice were more susceptible to systemic challenge with these bacteria than were wild-type mice. Transgenic Ncf1 mutant mice harboring the wild-type Ncf1 gene under the human CD68 promoter (MN(+) mice) gained the expression of NCF1 and functional NOX2 activity specifically in monocytes/macrophages, although minimal NOX2 activity was also detected in some CD11b(+)Ly6G(+) cells defined as neutrophils. MN(+) mice did not develop spontaneous infection and were more resistant to administered staphylococcal infections compared with MN(-) mice. Most strikingly, MN(+) mice survived after being administered Burkholderia cepacia, an opportunistic pathogen in CGD patients, whereas MN(-) mice died. Thus, monocyte/macrophage expression of functional NCF1 protected against spontaneous and administered bacterial infections.


Subject(s)
Membrane Glycoproteins/biosynthesis , Monocytes/enzymology , Monocytes/microbiology , NADPH Oxidases/biosynthesis , Reactive Oxygen Species/metabolism , Staphylococcal Infections/prevention & control , Animals , Anti-Bacterial Agents/pharmacology , Burkholderia Infections/enzymology , Burkholderia Infections/microbiology , Burkholderia Infections/prevention & control , Burkholderia cepacia/immunology , Humans , Mice , Mice, Inbred C57BL , Mice, Inbred DBA , Mice, Knockout , Mice, Transgenic , Monocytes/immunology , NADPH Oxidase 2 , NADPH Oxidases/physiology , Staphylococcal Infections/enzymology , Staphylococcal Infections/microbiology
7.
Innate Immun ; 18(4): 661-71, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22278934

ABSTRACT

Reactive oxygen species (ROS) are part of the weapons used by the immune system to kill and degrade infecting microorganisms. Bacteria can produce macromolecules, such as polysaccharides, that are able to scavenge ROS. Species belonging to the Burkholderia cepacia complex are involved in serious lung infection in cystic fibrosis patients and produce a characteristic polysaccharide, cepacian. The interaction between ROS and bacterial polysaccharides was first investigated by killing experiments, where bacteria cells were incubated with sodium hypochlorite (NaClO) with and without prior incubation with cepacian. The results showed that the polysaccharide had a protective effect towards bacterial cells. Cepacian was then treated with different concentrations of NaClO and the course of reactions was followed by means of capillary viscometry. The degradation products were characterised by size-exclusion chromatography, NMR and mass spectrometry. The results showed that hypochlorite depolymerised cepacian, removed side chains and O-acetyl groups, but did not cleave the glycosidic bond between glucuronic acid and rhamnose. The structure of some oligomers produced by NaClO oxidation is reported.


Subject(s)
Burkholderia Infections/immunology , Burkholderia cepacia/immunology , Cystic Fibrosis/immunology , Polysaccharides, Bacterial/metabolism , Reactive Oxygen Species/metabolism , Bacteriolysis/drug effects , Burkholderia Infections/complications , Burkholderia Infections/microbiology , Carbohydrate Metabolism/drug effects , Cystic Fibrosis/complications , Cystic Fibrosis/microbiology , Free Radical Scavengers/pharmacology , Humans , Immune Evasion , Magnetic Resonance Spectroscopy , Mass Spectrometry , Microbial Viability/drug effects , Polysaccharides, Bacterial/chemistry , Reactive Oxygen Species/chemistry , Sodium Hypochlorite/chemistry , Sodium Hypochlorite/metabolism
8.
Innate Immun ; 18(1): 140-54, 2012 Feb.
Article in English | MEDLINE | ID: mdl-21733976

ABSTRACT

Lipopolysaccharides are structural components within the cell walls of Gram-negative bacteria. The LPSs as microbe-associated molecular pattern (MAMP) molecules can trigger defense-related responses involved in MAMP-triggered immunity and basal resistance in plants, presumably from an initial perception event. LPS from Burkholderia cepacia as well as two fragments, the glycolipid, lipid A and the polysaccharide (OPS-core) chain, were used to treat Arabidopsis thaliana seedlings to evaluate the eliciting activities of the individual LPS sub-domains by means of Annealing Control Primer-based Differential Display transcript profiling. Genes found to be up-regulated encode for proteins involved in signal perception and transduction, transcriptional regulation and defense - and stress responses. Furthermore, genes encoding proteins involved in chaperoning, secretion, protein-protein interactions and protein degradation were differentially expressed. It is concluded that intact LPS, as well as the two sub-components, induced the expression of a broad range of genes associated with perception and defense as well as metabolic reprogramming of cellular activities in support of immunity and basal resistance. Whilst the lipid A and OPS moieties were able to up-regulate sub-sets of defense-associated genes over the same spectrum of categories as intact LPS, the up-regulation observed with intact LPS was the more comprehensive, suggesting that the lipid A and glycan molecular patterns of the molecule act as partial agonists, but that the intact LPS structure is required for full agonist activity.


Subject(s)
Arabidopsis/immunology , Arabidopsis/microbiology , Burkholderia cepacia/immunology , Lipopolysaccharides/immunology , Plant Diseases/immunology , Plant Diseases/microbiology , Arabidopsis/genetics , DNA, Plant/analysis , Gene Expression Profiling , Host-Pathogen Interactions , Immunity, Innate , Lipid A/chemistry , Lipopolysaccharides/chemistry , Lipopolysaccharides/metabolism , Molecular Structure , Seedlings/genetics , Seedlings/immunology , Seedlings/microbiology , Structure-Activity Relationship
9.
Glycobiology ; 21(2): 184-94, 2011 Feb.
Article in English | MEDLINE | ID: mdl-20943675

ABSTRACT

Lipopolysaccharides (LPSs) are major, indispensable cell surface components of Gram-negative bacteria that have diverse roles in bacterial pathogenesis of plants. Environmental strains of Burkholderia cepacia have been described as phytopathogens, growth promotors, biocontrol agents and bioremediation agents. We have previously shown that LPSs from B. cepacia can be recognized as microbe-associated molecular pattern molecules, to elicit defense responses in plants. Recent findings suggest that the lipid A moiety might be partially responsible for LPSs perception. These studies were extended by analysis of the structure and biological activity of the lipid A moiety of LPSs of B. cepacia(.) The full structure was determined by a combination of negative/positive-ion matrix-assisted laser desorption ionization (MALDI) mass spectrometry (MS) on intact and partially degraded substrates. B. cepacia lipid A was found to contain a tetra- or penta-acylated, 1,4'-diphosphorylated, ß-(1-6)-linked D-GlcN disaccharide and further substituted by L-Ara4N in position 4'. As primary fatty acids, R-configurated 16:0(3-OH) (amide-linked in 2 and 2') and 14:0(3-OH) (ester-linked in 3 and 3', nonstoichiometric) were identified. A secondary 14:0 was located at position 2'. Its biological activity to elicit defense-related responses was subsequently investigated by monitoring the changes in the transcriptome of Arabidopsis thaliana seedlings. Genes found to be upregulated code for proteins involved in signal perception and transduction, transcriptional regulation, defense and stress responses. Furthermore, genes encoding proteins involved in chaperoning, protein interactions and protein degradation were differentially expressed as part of the metabolic reprogramming of cellular activities in support of immunity and defense.


Subject(s)
Arabidopsis , Lipid A , Plant Immunity , Seedlings , Antigens, Bacterial/chemistry , Antigens, Bacterial/immunology , Antigens, Bacterial/pharmacology , Arabidopsis/genetics , Arabidopsis/immunology , Arabidopsis/metabolism , Burkholderia cepacia/chemistry , Burkholderia cepacia/immunology , Burkholderia cepacia/metabolism , Gene Expression Profiling , Lipid A/chemistry , Lipid A/immunology , Lipid A/pharmacology , Plant Immunity/drug effects , Seedlings/genetics , Seedlings/immunology , Seedlings/metabolism , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization , Structure-Activity Relationship , Up-Regulation
10.
Vaccine ; 28(5): 1318-24, 2010 Feb 03.
Article in English | MEDLINE | ID: mdl-19944788

ABSTRACT

Burkholderia cepacia is an opportunistic human pathogen associated with lung infections. Secretory proteins of B. cepacia are known to be involved in virulence and may mediate important host-pathogen interactions. In the present study, secretory proteins isolated from B. cepacia culture supernatant were separated using two-dimensional gel electrophoresis, followed by Western blot analysis to identify the immunogenic proteins. Mice antibodies raised to B. cepacia inactivated whole bacteria, outer membrane protein and culture filtrate antigen detected 74, 104 and 32 immunogenic proteins, respectively. Eighteen of these immunogenic proteins which reacted with all three antibodies were identified and might be potential molecules as a diagnostic marker or a putative candidate vaccine against B. cepacia infections.


Subject(s)
Bacterial Proteins/immunology , Burkholderia cepacia/immunology , Proteome/immunology , Proteomics/methods , Animals , Antibodies, Bacterial/immunology , Bacterial Proteins/metabolism , Bacterial Vaccines/immunology , Burkholderia Infections/diagnosis , Burkholderia Infections/immunology , Burkholderia Infections/prevention & control , Burkholderia cepacia/metabolism , Lung Diseases/diagnosis , Lung Diseases/immunology , Lung Diseases/microbiology , Lung Diseases/prevention & control , Male , Mice , Mice, Inbred BALB C , Proteome/metabolism
11.
J Immunol ; 183(1): 670-6, 2009 Jul 01.
Article in English | MEDLINE | ID: mdl-19535624

ABSTRACT

Burkholderia cenocepacia is an opportunistic pathogen of major concern for cystic fibrosis patients as well as immunocompromised cancer patients and transplant recipients. The mechanisms by which B. cenocepacia triggers a rapid health deterioration of the susceptible host have yet to be characterized. TLR and their key signaling intermediate MyD88 play a central role in the detection of microbial molecular patterns and in the initiation of an effective immune response. We performed a study to better understand the role of TLR-MyD88 signaling in B. cenocepacia-induced pathogenesis in the immunocompromised host, using an experimental murine model. The time-course of several dynamic parameters, including animal survival, bacterial load, and secretion of critical inflammatory mediators, was compared in infected and immunosuppressed wild-type and MyD88(-/-) mice. Notably, when compared with wild-type mice, infected MyD88(-/-) animals displayed significantly reduced levels of inflammatory mediators (including KC, TNF-alpha, IL-6, MIP-2, and G-CSF) in blood and lung airspaces. Moreover, despite a higher transient bacterial load in the lungs, immunosuppressed mice deficient in MyD88 had an unexpected survival advantage. Finally, we showed that this B. cenocepacia-induced life-threatening infection of wild-type mice involved the proinflammatory cytokine TNF-alpha and could be prevented by corticosteroids. Altogether, our findings demonstrate that a MyD88-dependent pathway can critically contribute to a detrimental host inflammatory response that leads to fatal pneumonia.


Subject(s)
Burkholderia Infections/prevention & control , Burkholderia cepacia , Immunocompromised Host/genetics , Myeloid Differentiation Factor 88/deficiency , Myeloid Differentiation Factor 88/genetics , Opportunistic Infections/prevention & control , Pneumonia, Bacterial/prevention & control , Animals , Burkholderia Infections/immunology , Burkholderia Infections/mortality , Burkholderia cepacia/growth & development , Burkholderia cepacia/immunology , Burkholderia cepacia/pathogenicity , Immunocompromised Host/immunology , Immunosuppressive Agents/administration & dosage , Mice , Mice, Inbred C57BL , Mice, Knockout , Myeloid Differentiation Factor 88/physiology , Opportunistic Infections/immunology , Opportunistic Infections/mortality , Pneumonia, Bacterial/immunology , Pneumonia, Bacterial/mortality , Survival Analysis , Tumor Necrosis Factor-alpha/deficiency , Tumor Necrosis Factor-alpha/genetics , Tumor Necrosis Factor-alpha/physiology
12.
J Immunol ; 180(11): 7764-73, 2008 Jun 01.
Article in English | MEDLINE | ID: mdl-18490781

ABSTRACT

Novel therapies to target lung inflammation are predicted to improve the lives of people with cystic fibrosis (CF) but specific antiinflammatory targets have not been identified. The goal of this study was to establish whether TLR5 signaling is the key molecular pathway mediating lung inflammation in CF, and to determine whether strategies to inhibit TLR5 can reduce the damaging inflammatory response. The innate immune responses were analyzed in both airway epithelial cells and primary PBMCs from CF patients and matched controls. Additionally, 151 clinical isolates of Pseudomonas aeruginosa from CF patients were assessed for motility and capacity to activate TLR5. Blood and airway cells from CF patients produced significantly more proinflammatory cytokine than did control cells following exposure to the CF pathogens P. aeruginosa and Burkholderia cepacia complex (p < 0.001). Stimulation with pure TLR ligands demonstrated that TLR signaling appears to mediate the excessive cytokine production occurring in CF. Using complementary approaches involving both neutralizing Ab targeting TLR5 and flagellin-deficient bacteria, we established that inhibition of TLR5 abolished the damaging inflammatory response generated by CF airway cells following exposure to P. aeruginosa (p < 0.01). The potential therapeutic value of TLR5 inhibition was further supported by our demonstration that 75% of clinical isolates of P. aeruginosa retained TLR5 activating capacity during chronic CF lung infection. These studies identify the innate immune receptor TLR5 as a novel antiinflammatory target for reducing damaging lung inflammation in CF.


Subject(s)
Cystic Fibrosis/immunology , Epithelial Cells/metabolism , Flagellin/metabolism , Leukocytes, Mononuclear/immunology , Toll-Like Receptor 5/antagonists & inhibitors , Toll-Like Receptor 5/immunology , Burkholderia cepacia/immunology , Cystic Fibrosis/metabolism , Cystic Fibrosis/therapy , Epithelial Cells/immunology , Epithelial Cells/microbiology , Flagellin/immunology , Humans , Immunity, Innate , Leukocytes, Mononuclear/metabolism , Leukocytes, Mononuclear/microbiology , Lung/immunology , Lung/microbiology , Pseudomonas aeruginosa/immunology , Toll-Like Receptor 5/metabolism
13.
Immunol Invest ; 37(1): 19-27, 2008.
Article in English | MEDLINE | ID: mdl-18214797

ABSTRACT

Pseudomonas aeruginosa and Burkholderia cenocepacia are opportunistic pathogens causing important chronic pulmonary infections in patients affected by cystic fibrosis (CF). The interplay of bacterial and host factors involved in the establishment and evolution of these infections needs further clarification. We investigated the susceptibility of P. aeruginosa and B. cenocepacia derived from CF patients or from the environment to hyperimmune sera obtained from the same CF patients and evaluated the amount of specific antibodies present in these sera. Our data indicate that the bactericidal activity of human serum against these two bacteria is mostly complement-mediated, and that the mucous layer probably confers serum-resistance to B. cenocepacia. The mean amount of antibodies against P. aeruginosa was higher than that against B. cenocepacia. The contribution of these data to the assessment of the importance of the humoral immune response in CF pulmonary infections by Pseudomonas and Burkholderia is briefly discussed.


Subject(s)
Antibodies, Bacterial/blood , Burkholderia cepacia/immunology , Cystic Fibrosis/immunology , Cystic Fibrosis/microbiology , Immune Sera/pharmacology , Pseudomonas aeruginosa/immunology , Blood Bactericidal Activity , Burkholderia Infections/complications , Burkholderia Infections/immunology , Burkholderia Infections/microbiology , Complement System Proteins/pharmacology , Cystic Fibrosis/complications , Enzyme-Linked Immunosorbent Assay , Humans , Pseudomonas Infections/complications , Pseudomonas Infections/immunology , Pseudomonas Infections/microbiology , Sputum/microbiology
14.
Org Biomol Chem ; 5(16): 2704-8, 2007 Aug 21.
Article in English | MEDLINE | ID: mdl-18019546

ABSTRACT

We report a very high yielding first total synthesis of trisaccharide 5, alpha-D-Rhap-(1 --> 3)-alpha-D-Rhap-(1 --> 4)-alpha-D-Galp, corresponding to the repeating unit 1 of an O-polysaccharide present in the lipopolysaccharide of clinical isolate of Burkholderia cepacia. The approach included two successive glycosylations, based on D-rhamnosyl trichloroacetimidate donors 12 and 14. The oligosaccharide 5 has been further functionalized by photochemical coupling or cross-metathesis with non-natural amino acid derivatives. Trisaccharidylamino acids 16 and 17 are now available, with the aim of preparing a novel synthetic carbohydrate-based vaccine.


Subject(s)
Burkholderia cepacia , Carbohydrates/chemical synthesis , Polysaccharides, Bacterial/chemistry , Trisaccharides/chemical synthesis , Vaccines/chemical synthesis , Burkholderia cepacia/immunology , Carbohydrate Conformation , Carbohydrate Sequence , Carbohydrates/chemistry , Carbohydrates/immunology , Trisaccharides/chemistry , Vaccines/chemistry
15.
Clin Vaccine Immunol ; 14(11): 1529-31, 2007 Nov.
Article in English | MEDLINE | ID: mdl-17804613

ABSTRACT

The serological diagnosis of melioidosis is carried out using the indirect hemagglutination assay. We looked at the reactivity of sera from culture-proven cases of melioidosis from north Queensland against antigens derived from Burkholderia pseudomallei, B. thailandensis, and B. cepacia. Cross-reactivity between sera from culture-positive cases of melioidosis and B. thailandensis was demonstrated.


Subject(s)
Antibodies, Bacterial/blood , Burkholderia cepacia/immunology , Burkholderia pseudomallei/immunology , Burkholderia/immunology , Hemagglutination Tests , Melioidosis/diagnosis , Antibodies, Bacterial/immunology , Antigens, Bacterial/immunology , Burkholderia Infections/diagnosis , Burkholderia Infections/immunology , Burkholderia Infections/microbiology , Humans , Melioidosis/immunology , Melioidosis/microbiology , Queensland
16.
PLoS Pathog ; 3(3): e41, 2007 Mar.
Article in English | MEDLINE | ID: mdl-17381241

ABSTRACT

We showed previously that eiger, the Drosophila tumor necrosis factor homolog, contributes to the pathology induced by infection with Salmonella typhimurium. We were curious whether eiger is always detrimental in the context of infection or if it plays a role in fighting some types of microbes. We challenged wild-type and eiger mutant flies with a collection of facultative intracellular and extracellular pathogens, including a fungus and Gram-positive and Gram-negative bacteria. The response of eiger mutants divided these microbes into two groups: eiger mutants are immunocompromised with respect to extracellular pathogens but show no change or reduced sensitivity to facultative intracellular pathogens. Hence, eiger helps fight infections but also can cause pathology. We propose that eiger activates the cellular immune response of the fly to aid clearance of extracellular pathogens. Intracellular pathogens, which can already defeat professional phagocytes, are unaffected by eiger.


Subject(s)
Beauveria/pathogenicity , Burkholderia cepacia/pathogenicity , Drosophila Proteins/physiology , Drosophila/microbiology , Gram-Positive Bacteria/pathogenicity , Membrane Proteins/physiology , Animals , Beauveria/immunology , Burkholderia cepacia/immunology , Drosophila/immunology , Drosophila Proteins/genetics , Gene Expression Regulation , Gram-Positive Bacteria/immunology , Immunity, Innate/physiology , Immunocompromised Host/immunology , Membrane Proteins/genetics , Mutation
17.
Chemistry ; 13(12): 3501-11, 2007.
Article in English | MEDLINE | ID: mdl-17219455

ABSTRACT

Members of genus Burkholderia include opportunistic Gram-negative bacteria that are responsible for serious infections in immunocompromised and cystic fibrosis (CF) patients. The Burkholderia cepacia complex is a group of microorganisms composed of at least nine closely related genomovars. Among these, B. cenocepacia is widely recognized to cause epidemics associated with excessive mortality. Species that belong to this strain are problematic CF pathogens because of their high resistance to antibiotics, which makes respiratory infections difficult to treat and impossible to eradicate. Infection by these bacteria is associated with higher mortality in CF and poor outcomes following lung transplantation. One virulence factor contributing to this is the pro-inflammatory lipopolysaccharide (LPS) molecules. Thus, the knowledge of the lipopolysaccharide structure is an essential prerequisite to the understanding of the molecular mechanisms involved in the inflammatory process. Such data are instrumental in aiding the design of antimicrobial compounds and for developing therapeutic strategies against the inflammatory cascade. In particular, defining the structure of the LPS from B. cenocepacia ET-12 clone LMG 16656 (also known as J2315) is extremely important given the recent completion of the sequencing project at the Sanger Centre using this specific strain. In this paper we address this issue by defining the pro-inflammatory activity of the pure lipopolysaccharide, and by describing its full primary structure. The activity of the lipopolysaccharide was tested as a stimulant in human myelomonocytic U937 cells. The structural analysis was carried out by compositional analysis, mass spectrometry and 2D NMR spectroscopy on the intact lipooligosacchride (LOS) and its fragments, which were obtained by selective chemical degradations.


Subject(s)
Burkholderia Infections/pathology , Burkholderia cepacia/pathogenicity , Cystic Fibrosis/pathology , Inflammation/pathology , Lipopolysaccharides/chemistry , Lipopolysaccharides/pharmacology , Burkholderia Infections/epidemiology , Burkholderia Infections/microbiology , Burkholderia cepacia/genetics , Burkholderia cepacia/immunology , Cystic Fibrosis/epidemiology , Cystic Fibrosis/microbiology , Disease Outbreaks , Humans , Lipopolysaccharides/immunology , Magnetic Resonance Spectroscopy , U937 Cells/drug effects , U937 Cells/pathology , Virulence
18.
Article in Russian | MEDLINE | ID: mdl-16028514

ABSTRACT

The evidence has been obtained that various species, as well as individual strains having pathogenicity factors, produced different effect on the functional activity of immunocompetent B and T lymphocytes of mice infected intraperitoneally. The injection of live P. aerruginosa PA 103 and B. cepacia 8240 cells resulted in imunosuppression of antibody-forming cells, synthesizing antibodies to heterologous antigens. On the contrary, in the animals infected with B. cepacia 8236 the functional activity of B lymphocytes increased. An increase in the proliferative activity of spleen cells was noted in the presence of T and B mitogens after the infection of mice with P. aeruginosa PA 103 in comparison with B. cepacia 8236 and B. cepacia 8240 which produced a faintly pronounced modulating effect. The pathogenesis mechanisms of infections induced by these microorganisms as well as the development of chronic, persisting forms of the infectious process are discussed.


Subject(s)
Burkholderia Infections/immunology , Burkholderia cepacia/pathogenicity , Pseudomonas Infections/immunology , Pseudomonas aeruginosa/pathogenicity , Animals , Antibodies, Bacterial/biosynthesis , B-Lymphocytes/immunology , Burkholderia cepacia/immunology , Immunity, Cellular , Immunosuppression Therapy , Lymphocyte Activation , Lymphocytes/immunology , Male , Mice , Mice, Inbred BALB C , Pseudomonas aeruginosa/immunology , Spleen/cytology , Spleen/immunology , T-Lymphocytes/immunology , Virulence Factors/immunology
19.
Phytochemistry ; 65(22): 2957-66, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15504430

ABSTRACT

Bacterial LPS have the ability to act as modulators of the innate immune response in plants. Complex and largely unresolved perception systems exist for LPS on the plant cell surfaces that lead to the activation of multiple intracellular defense signaling pathways. The aim of the present study was to investigate the perception mechanism of cultured Nicotiana tabacum cells towards LPS from Burkholderia cepacia (LPS(B.cep.)), with regard to the role of protein phosphorylation during signal perception-related responses to gain a better understanding of the chemosensory perception of LPS elicitor signals in plant cells. In vivo labeling of protein phosphorylation events during signal transduction indicated the rapid phosphorylation of several proteins with the hyperphosphorylation of two proteins of 28 and 2 kDa, respectively. Significant differences and de novo LPS-induced phosphorylation were also observed with two-dimensional analysis. The protein kinase inhibitor, staurosporine, totally inhibited the extracellular alkalinization response induced by LPS(B.cep.), while the oxidative burst was only partially inhibited by staurosporine. Inhibition of protein phosphatase activity by calyculin A intensified the LPS(B.cep.) responses. The results indicate that perception- and signal transduction responses during LPS(B.cep.) elicitation of tobacco cells require a balance between the actions of certain protein kinases and protein phosphatases.


Subject(s)
Burkholderia cepacia/immunology , Lipopolysaccharides/immunology , Nicotiana/immunology , Nicotiana/metabolism , Plant Proteins/metabolism , Cells, Cultured , Marine Toxins , Oxazoles/pharmacology , Phosphoprotein Phosphatases/antagonists & inhibitors , Phosphorylation , Protein Kinase Inhibitors/pharmacology , Protein Processing, Post-Translational , Receptors, Cell Surface , Respiratory Burst , Signal Transduction , Staurosporine/pharmacology , Nicotiana/drug effects
20.
FEMS Immunol Med Microbiol ; 38(3): 273-82, 2003 Oct 15.
Article in English | MEDLINE | ID: mdl-14522463

ABSTRACT

Burkholderia cepacia causes pulmonary infection with high mortality in cystic fibrosis (CF) patients which is likely to involve interaction with respiratory epithelium. In this study the pro-inflammatory properties of B. cepacia were examined using a range of respiratory epithelial cell lines. B. cepacia and cell-free culture supernatants were used to stimulate cell lines with (SigmaCFTE29o- and IB3) and without (A549) the CF transmembrane conductance regulator mutation (CFTR), together with corrected cell lines (C38 and S9). Interleukin (IL)-6 and IL-8, but not GM-CSF or IL-1beta, were released from all the cell lines whereas PGE(2) (prostaglandin E(2)) was released from the A549, IB3 and S9 cell lines only. Nuclear factor (NF)-kappaB activation preceded cytokine release and suppression of NF-kappaB activity diminished cytokine release. These studies indicated that B. cepacia secretory products are potent pro-inflammatory agents for respiratory epithelium and suggest functional CFTR is not required for cytokine or prostanoid responses.


Subject(s)
Burkholderia cepacia/pathogenicity , Cystic Fibrosis/microbiology , Cytokines/metabolism , Dinoprostone/metabolism , Inflammation , Respiratory Mucosa/metabolism , Respiratory Mucosa/microbiology , Burkholderia cepacia/immunology , Cell Line , Cell Line, Tumor , Cystic Fibrosis/immunology , Cystic Fibrosis/metabolism , Cystic Fibrosis Transmembrane Conductance Regulator/genetics , Cystic Fibrosis Transmembrane Conductance Regulator/physiology , Granulocyte-Macrophage Colony-Stimulating Factor/metabolism , Humans , Interleukin-1/metabolism , Interleukin-6/metabolism , Interleukin-8/metabolism , Mutation , NF-kappa B/metabolism , Prostaglandin-Endoperoxide Synthases/metabolism , Respiratory Mucosa/immunology , Transcriptional Activation
SELECTION OF CITATIONS
SEARCH DETAIL
...